|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
19.30(B) |
Last
Volume: |
1,186,610 |
Avg
Vol: |
1,898,196 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
16,441 |
67,902 |
123,113 |
368,767 |
Total Sell Value |
$1,241,296 |
$5,004,391 |
$8,902,469 |
$27,563,219 |
Total People Sold |
1 |
4 |
6 |
10 |
Total Sell Transactions |
1 |
6 |
8 |
16 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
West Thomas A. |
Div President & GM, Diagnostic |
|
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,086 |
35,664 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2018-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
104,322 |
1,542,116 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,119 |
1,437,794 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,388 |
55,570 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,086 |
41,182 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2018-11-05 |
4 |
D |
$39.99 |
$10,717 |
D/D |
(268) |
12,815 |
|
- |
|
Griffin John M. |
General Counsel |
|
2018-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
17,267 |
71,944 |
|
- |
|
Griffin John M. |
General Counsel |
|
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,503 |
54,677 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2018-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,395 |
16,147 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2018-11-05 |
4 |
D |
$39.99 |
$9,158 |
D/D |
(229) |
10,752 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
775 |
10,981 |
|
- |
|
West Thomas A. |
Div President & GM, Diagnostic |
|
2018-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,064 |
32,970 |
|
- |
|
Stamoulis Christiana |
Director |
|
2018-10-02 |
4 |
AS |
$40.70 |
$1,260,481 |
D/D |
(30,967) |
35,039 |
|
- |
|
Stamoulis Christiana |
Director |
|
2018-10-02 |
4 |
OE |
$15.29 |
$473,485 |
D/D |
30,967 |
66,006 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2018-09-19 |
4 |
AS |
$41.50 |
$142,636 |
D/D |
(3,437) |
13,083 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2018-09-19 |
4 |
OE |
$17.09 |
$58,738 |
D/D |
3,437 |
16,520 |
|
- |
|
Crawford Sally |
Director |
|
2018-09-17 |
4 |
AS |
$39.54 |
$524,169 |
D/D |
(13,257) |
154,444 |
|
- |
|
Crawford Sally |
Director |
|
2018-09-17 |
4 |
OE |
$17.51 |
$232,130 |
D/D |
13,257 |
167,701 |
|
- |
|
Mcmahon Robert W. |
Chief Financial Officer |
|
2018-08-02 |
4 |
D |
$42.12 |
$324,282 |
D/D |
(7,699) |
112,244 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-05-29 |
4 |
AS |
$38.52 |
$389,322 |
D/D |
(10,107) |
39,096 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-05-29 |
4 |
OE |
$23.82 |
$184,986 |
D/D |
7,766 |
46,862 |
|
- |
|
Mcmahon Robert W. |
Chief Financial Officer |
|
2018-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,347 |
119,943 |
|
- |
|
Oberton Karleen Marie |
Corp. VP & Chief Acctg Officer |
|
2018-05-25 |
4 |
D |
$38.92 |
$6,033 |
D/D |
(155) |
9,993 |
|
- |
|
Oberton Karleen Marie |
Corp. VP & Chief Acctg Officer |
|
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
525 |
10,148 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2018-05-25 |
4 |
D |
$38.92 |
$41,644 |
D/D |
(1,070) |
41,437 |
|
- |
|
824 Records found
|
|
Page 16 of 33 |
|
|